GlassScriptPhysician profile
Terry Roger Lowe
NPI 1508860123
$7,711.01
in general payments reported to CMS, 2019-2025
38 companies · $1,419 in 2025
The $1,419 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $924 · 2020: $1,140 · 2021: $1,384 · 2022: $995 · 2023: $1,138 · 2024: $711 · 2025: $1,419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,268.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,589.76 | 2019-2025 | Xifaxan |
| Abbvie INC. | $1,085.06 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $867.73 | 2019-2025 | Airsupra, Farxiga |
| Pfizer INC. | $671.29 | 2019-2023 | |
| Amgen INC. | $472.96 | 2019-2025 | Evenity, Repatha, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $402.16 | 2019-2023 | Trintellix |
| Novo Nordisk INC | $369.13 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $312.45 | 2020-2024 | Shingrix, Arexvy, Boostrix |
| Allergan, INC. | $305.75 | 2019-2020 | |
| Lilly USA, LLC | $249.85 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.69 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $107.13 | 2019-2023 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Exact Sciences Corporation | $96.95 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Biogen, INC. | $88.36 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $67.78 | 2019-2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.